Quinidine, Serum or Urine
Quinidine is a Class 1a antiarrhythmic drug. It is used to control arrhythmia (irregular heartbeat) by blocking sodium channels in cardiac (heart) muscle. Specifically, it is used to control atrial fibrillation, atrial flutter and serious ventricular arrhythmias. Quinidine has also been used to treat malarial infections caused by Plasmodium falciparum (although not used as a first choice). Metabolism of quinidine is carried out in the liver, and shows a half-life between 4 and 17 hours. Several metabolites of quinidine also show antiarrythmic activity. Peak concentrations occur from 2 – 6 hours when taken orally, or 0 – 2 hours with either intramuscular or intravenous injection. Between 70 and 90% of the circulating drug is bound to protein. Quinidine is eliminated from the body primarily through the hepatic system, though renal failure may lead to accumulation of biologically active metabolites. Any disorder affecting one or both of these systems will affect the amount of circulating drug, and therapeutic monitoring will need to be done more often to avoid toxicity. Toxic side effects may include nausea, headache, tinnitus, vomiting, diarrhea, hypotension, bradycardia, eighth cranial nerve damage, and arrhythmia.
- Monitored to avoid toxicity
- Ensure therapeutic levels
Increased in:
- Toxicity
Decreased in:
- Under dosage
| Category | µg/mL |
| Therapeutic | 2.0–5.0 |
| Toxic | >5.0 |
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA), high performance liquid chromatography with mass spectrometry (LCMS/MS).
Serum (Red top) preferred, Plasma EDTA (Lavender), Heparin (Green) & Citrate (Light Blue).
Urine collected in a sterile urine cup.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).
- Lehmann CA. Saunders Manual of Clinical Laboratory Science. Philadelphia. W.B. Saunders Company (1998).